• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,741.82 238.22
( 0.31%)
Global Indices
Nasdaq
52,357.11 -589.04
(-1.11%)
Dow Jones
7,503.65 -21.20
(-0.28%)
Hang Seng
67,966.49 1,147.44
(1.72%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Morarka Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
511549
INE367A01015
257.3717778
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
19.19
27.47
EPS(TTM)
Face Value()
Div & Yield %
3.18
10
2.46
 

Ind-Swift Laboratories consolidated net profit declines 93.20% in the March 2026 quarter
May 29,2026
Net profit of Ind-Swift Laboratories declined 93.20% to Rs 15.11 crore in the quarter ended March 2026 as against Rs 222.27 crore during the previous quarter ended March 2025. Sales rose 22.82% to Rs 169.79 crore in the quarter ended March 2026 as against Rs 138.24 crore during the previous quarter ended March 2025.

For the full year,net profit declined 83.46% to Rs 41.42 crore in the year ended March 2026 as against Rs 250.48 crore during the previous year ended March 2025. Sales rose 14.17% to Rs 641.29 crore in the year ended March 2026 as against Rs 561.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales169.79138.24 23 641.29561.71 14
OPM %12.11-6.66 -7.03-3.45 -
PBDT25.2222.02 15 90.6659.08 53
PBT17.1114.58 17 60.0634.60 74
NP15.11222.27 -93 41.42250.48 -83